NELSON CEPEDA: Open Payments
NPI 1598477317 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,991 in 151 payments from 18 companies in 2025. Trend: 2023 $931 · 2024 $3,326 · 2025 $2,991
Food & beverage: $2,937Education: $54
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 27 | $668 |
| ABBVIE INC. | 31 | $332 |
| Eisai Inc. | 13 | $302 |
| Lundbeck LLC | 17 | $289 |
| LivaNova USA, Inc. | 11 | $261 |
| SK Life Science, Inc. | 10 | $206 |
| Otsuka America Pharmaceutical, Inc. | 13 | $158 |
| Otter Pharmaceuticals, LLC | 6 | $154 |
| EMD Serono, Inc. | 1 | $125 |
| JAZZ PHARMACEUTICALS INC. | 5 | $107 |
Products named: Leqembi, Fintepla, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, REXULTI, Briviact, VYEPTI, SYMPAZAN, Nayzilam.
Industry payments across TX — which companies pay providers there.
